0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Invited Commentary |  FREE ONLINE FIRST
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncol. Published online June 23, 2016. doi:10.1001/jamaoncol.2016.0283

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA Oncol. Published online June 23, 2016. doi:10.1001/jamaoncol.2016.1726
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint |  ONLINE FIRST
Kai Ruggeri, PhD; Áine Maguire, MSc; Gordon Cook, MD
JAMA Oncol. Published online June 23, 2016. doi:10.1001/jamaoncol.2016.1782

JAMA Ophthalmology | 
Original Investigation |  FREE ONLINE FIRST
Stanford C. Taylor, MD; Julia B. Huecker, MS; Mae O. Gordon, PhD; et al.
JAMA Ophthalmol. Published online June 23, 2016. doi:10.1001/jamaophthalmol.2016.1678

JAMA Ophthalmology | 
Original Investigation |  ONLINE FIRST
Marissa L. Weber, MD; Michelle C. Liang, MD; Keith T. Flaherty, MD; et al.
JAMA Ophthalmol. Published online June 16, 2016. doi:10.1001/jamaophthalmol.2016.0090
Includes: Supplemental Content

JAMA Oncology | 
Research Letter |  ONLINE FIRST
David Liu, MD, MPH, MS; Elizabeth R. Plimack, MD, MS; Jean Hoffman-Censits, MD; et al.
JAMA Oncol. Published online June 16, 2016. doi:10.1001/jamaoncol.2016.1056

JAMA Oncology | 
Original Investigation |  Open Access ONLINE FIRST
Hsu-Chih Chien, MS; Yea-Huei Kao Yang, BSPharm; Jane P. F. Bai, AM, PhD
JAMA Oncol. Published online June 16, 2016. doi:10.1001/jamaoncol.2016.1269
Includes: Supplemental Content

JAMA Oncology | 
Review |  ONLINE FIRST
Adrian G. Sacher, MD; Leena Gandhi, MD, PhD
JAMA Oncol. Published online June 16, 2016. doi:10.1001/jamaoncol.2016.0639

JAMA Oncology | 
Research Letter |  ONLINE FIRST
Hemanth Kumar, MD; Tito Fojo, MD, PhD; Sham Mailankody, MBBS
JAMA Oncol. Published online June 09, 2016. doi:10.1001/jamaoncol.2016.0931

JAMA Oncology | 
Original Investigation |  Open Access ONLINE FIRST
Aleix Prat, MD, PhD; Maggie C. U. Cheang, PhD; Patricia Galván, BS; et al.
JAMA Oncol. Published online June 09, 2016. doi:10.1001/jamaoncol.2016.0922
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Original Investigation  | 
Physician-Industry Interactions and Anti–Vascular Endothelial Growth Factor Use Among US Ophthalmologists
Stanford C. Taylor, MD; Julia B. Huecker, MS; Mae O. Gordon, PhD; et al.
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA Oncology
Viewpoint  | 
The “Next Big Thing” in Treatment for Relapsed or Refractory Multiple Myeloma May Be Held Back by Design—Between the Lines
Kai Ruggeri, PhD; Áine Maguire, MSc; Gordon Cook, MD